Secteur Taysha Gene Therapies, Inc.

Actions

TSHA

US8776191061

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 24/07/2026 Varia. 5j. Varia. 1 janv.
5,520 USD -5,32% Graphique intraday de Taysha Gene Therapies, Inc. -7,54% +0,36%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
-5,32%-7,54%-19,53%-13,75%+0,36%+105,20%+700,81%-70,53% - 1,86 Md
-1,92%-1,57%+17,58%+24,76%+37,91%+48,70%+84,37%-18,83% - 55,92 Md
+0,93%+7,22%-1,06%+17,36%+12,22%+64,67%+63,56%+200,26%+6 097,23% 56,67 Md
-2,97%-2,44%-1,42%-15,38%-6,17%-22,05%-17,74%-68,32% - 23,28 Md
-0,46%-0,50%+4,67%-25,66%-38,57%+3,36%+407,21%+341,09%+866,73% 23,28 Md
-0,36%-0,56%+25,56%+15,27%+24,36%+36,00%-3,93%-69,85% - 20,54 Md
-1,34%-0,63%+9,95%+7,74%-7,33%+29,60%-32,53%-33,86%+63,63% 17,78 Md
-1,44%-1,63%+29,15%+10,63%+31,06%+37,07%+589,93% - - 15,9 Md
-1,30%-9,92%+14,98%+100,16%+167,88%+160,67%+284,37%+1 494,96%+602,10% 14,64 Md
-0,50%-0,56%+7,85%+20,24%+26,33%+21,96%+181,21%+230,96%+537,90% 13,99 Md
-1,36%+19,93%+7,13%+15,05%+28,94%+437,69%+137,25%+25,20%+1 415,04% 12,22 Md
+0,21%-0,19%+6,05%+4,97%-6,50%+77,50%+152,38%+513,95% - 12,53 Md
-3,21%-2,26%+16,37%-23,70%-11,95%-30,61%+167,47%+87,91% - 12,08 Md
-8,81%-0,73%-4,14%-38,66%-21,90%-51,23%+583,00%+70,75%+91,05% 11,63 Md
-1,44%+0,47%+0,91%+23,30%+27,07%+112,87%+146,76%+178,03%+719,70% 11,12 Md
-4,70%-2,12%+24,46%-20,53%+15,56%+25,11%+91,26%-12,93% - 8,82 Md
+0,10%-0,21%+133,17%+117,42%+79,87%+170,27%+347,51%+319,07% - 8,82 Md
+2,14%+8,51%+5,23%+47,50%+211,75%+473,44%+588,67%-37,73%-12,15% 8,79 Md
-4,27%-3,92%+35,99%+23,73%+14,49%+24,13%+323,29%+313,02% - 8,27 Md
-1,76%-2,46%+5,20%-10,05%+18,47%+49,92%+12,61%+142,72% - 8,03 Md
Moyenne -1,66%+1,82%+15,91%+14,02%+30,19%+88,71%+240,37%+189,78%+1 153,47% 17,31 Md
Moyenne pondérée par Capi. -1,05%+2,21%+13,16%+14,20%+24,87%+68,64%+173,19%+170,50%+2 406,66%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action TSHA
  4. Secteur Taysha Gene Therapies, Inc.